Scientific information services provider FIZ Karlsruhe, Germany, has entered into an agreement with US-based SequenceBase Corporation for promoting the USGENE in-house version more effectively in Europe. USGENE is a resource for life-science intellectual property professionals, providing unrivalled searchable access to all available peptide and nucleotide sequences from the published applications and issued patents of the United States Patent and Trademark Office (USPTO). This agreement adds to the already existing partnership between SequenceBase Corp. and FIZ Karlsruhe with respect to the offering of USGENE via the latter's online-service STN International.
Under the new agreement, FIZ Karlsruhe will act as a sales agent on behalf of SequenceBase Corporation. In this capacity, FIZ Karlsruhe will sell and market the USGENE database in-house version to customers and prospective customers of the SequenceBase Corporation in enterprises and institutes throughout Europe. The database is also available via STN International.
Scientists working in drug discovery operations, academia, and life sciences can now benefit from the customised in-house version of the USGENE database. USGENE data are available in customised subscription formats to suit various in-house molecular biology patent information needs. The database can be implemented and integrated in other life science products such as Laboratory Information Management Systems (LIMS), Drug Discovery Platforms, Patent Portals, Web Host interfaces and other online information services. USGENE data can be provided in industry standard or customised data formats to suit particular in-house needs.
According to the customers' needs, the USGENE database can be purchased by segments of data such as class, art unit, patent assignee, inventor, publication date, or any other desired fields. The entire back file from 1982 to date can be licenced; regular weekly updates are provided to subscribers within 3 days of publication by the United States Patent Office.
